Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07195916
What this trial is testing

Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Solid TumorsHematologic Malignancies
Incyte Corporation 280
Not applicableLooking for participantsNCT07657325
What this trial is testing

Study on MRD Prediction of Efficacy of Toripalimab in the Treatment of High-risk Recurrent Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)
Tianjin Medical University Second Hospital 110
Testing effectiveness (Phase 2)Active Not RecruitingNCT01038778
What this trial is testing

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Ended earlyNCT00704938
What this trial is testing

Gene-Modified Lymphocytes, High-Dose Aldesleukin, and Vaccine Therapy in Treating Patients With Progressive or Recurrent Metastatic Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
National Institutes of Health Clinical Center (CC) 3
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)Study completedNCT00003091
What this trial is testing

High-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)
Hoag Memorial Hospital Presbyterian 40
Not applicableStudy completedNCT00617799
What this trial is testing

Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma

Who this might be right for
Kidney CancerMelanoma (Skin)
University of Nebraska 15
Testing effectiveness (Phase 2)Study completedNCT00554515
What this trial is testing

The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma

Who this might be right for
Metastatic Renal Cell Carcinoma
Beth Israel Deaconess Medical Center 123
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741617
What this trial is testing

A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma

Who this might be right for
Urologic Neoplasms
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07840001
What this trial is testing

Neoadjuvant Belzutifan Plus Pembrolizumab in High-Risk, Locally Advanced Clear Cell Renal Cell Carcinoma

Who this might be right for
Locally Advanced Clear Cell Renal Cell Carcinoma
Peter MacCallum Cancer Centre, Australia 30
Early research (Phase 1)Study completedNCT00002854
What this trial is testing

High-Dose Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
City of Hope Medical Center 33
Early research (Phase 1)Active Not RecruitingNCT03589339
What this trial is testing

NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Who this might be right for
RadiotherapyImmunotherapyMicrosatellite Instability-High Solid Malignant Tumour+8 more
Nanobiotix 145
Testing effectiveness (Phase 2)Ended earlyNCT03277352
What this trial is testing

INCAGN01876 in Combination With Immune Therapies in Subjects With Advanced or Metastatic Malignancies

Who this might be right for
Advanced MalignanciesMetastatic Cancer
Incyte Biosciences International Sàrl 10
Not applicableStudy completedNCT02150369
What this trial is testing

Interleukin-2-Induced Cognitive/Affective/Sleep Symptoms

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic MelanomaHigh-dose Interleukin-2
Duke University 32
Early research (Phase 1)Study completedNCT00418496
What this trial is testing

Interleukin-2 With Sorafenib (BAY 43-9006) for Unresectable or Metastatic Clear Cell Renal Carcinoma (RCC) and Metastatic Melanoma

Who this might be right for
Renal CancerMelanoma
Ohio State University Comprehensive Cancer Center 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02306954
What this trial is testing

Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer

Who this might be right for
Renal Cell Carcinoma
Providence Health & Services 84
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Very early researchStudy completedNCT00278369
What this trial is testing

Pilot Study of Denileukin Diftitox Plus High-Dose IL-2 for Patients With Metastatic Renal Cancer

Who this might be right for
Kidney Cancer
Northwestern University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602101
What this trial is testing

Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
RenJi Hospital 33
Testing effectiveness (Phase 2)Ended earlyNCT00788125
What this trial is testing

Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
City of Hope Medical Center 7
Next Page